Abstract
Morris IV et al. adapted a mouse model of human pancreatic ductal adenocarcinoma and found that p53-dependent metabolic changes restrain tumour progression through α-ketoglutarate accumulation and promotion of a premalignant cell fate.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have